A potential vaccine strategy for asthma and allied atopic diseases during early childhood

The Lancet

Volumn 344, Issue 8920, 1994, Pages 456-458

  Holt, Pg ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA VACCINE; UNCLASSIFIED DRUG;

ASTHMA; ATOPY; CHILD; CHILD CARE; HEALTH CARE POLICY; HUMAN; INTRANASAL DRUG ADMINISTRATION; MEDICAL ETHICS; PRIORITY JOURNAL; PROPHYLAXIS; SHORT SURVEY; VACCINATION;

EID: 0028031306     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)91776-0     Document Type: Article

References (27)

1. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties
2. Lymphokine control of in vivo immunoglobulin isotype selection
3. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-&ggr
4. Interleukin 4 induces synthesis of IgE and IgG4 in human B cells
5. + T lymphocytes in atopic patients
6. Allergen-specific and bacterial-antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production
7. The biological reactions of the vegetable proteins I anaphylaxis
8. The regulation of immune responses to dietary protein antigens
9. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGF-β following antigenic specific triggering
10. Orally inducible immune unresponsiveness is abrogated by IFN-y treatment
11. + T cell dependent immune deviation resulting in selective suppression of IgE production
12. T-cell lymphokine response to orally administered antigens during priming and unresponsiveness
13. Suppression of IgE responses following antigen inhalation: a natural homeostatic mechanism which limits sensitization to aeroallergens
14. Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance
15. Suppression of IgE responses in inbred rats by repeated respiratory tract exposure to antigen: responder phenotype influences isotype specificity of induced tolerance
16. Suppression of IgE responses by antigen inhalation: studies on the role of genetic and environmental factors
17. Primary sensitisation to inhalant allergens during infancy
18. Postnatal development of respiratory mucosal immune function in the rat regulation of IgE responses to inhaled allergen
19. Ontogeny of orally induced tolerance to soluble proteins in mice: I priming and tolerance in newborns
20. Immune responses to fed protein antigens in mice: 3 systemic tolerance or printing is related to age at which antigen is first encountered
21. Inhibition of T-cell and antibody responses to house dust mite allergen by inhalation or the dominant epitope in naive and sensitive mice
22. Clinical symptoms and IgE responses to common proteins and inhalants in the first 7 years of life
23. Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children
24. Induction of TH1 and TH2 responses: a key role for the natural immune response?
25. 1
26. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses
27. The natural history of IgE sensitisation and atopic disease in early childhood